Science News
from research organizations

Blood vessel cells help tumors evade the immune system

Date:
August 24, 2015
Source:
Karolinska Institutet
Summary:
A new study is the first to suggest that cells in the tumor blood vessels contribute to a local environment that protects the cancer cells from tumor-killing immune cells. The results can contribute to the development of better immune-based cancer therapies.
Share:
FULL STORY

A study by researchers at Sweden's Karolinska Institutet is the first to suggest that cells in the tumour blood vessels contribute to a local environment that protects the cancer cells from tumour-killing immune cells. The results, which are being published in the Journal of the National Cancer Institute, can contribute to the development of better immune-based cancer therapies.

Immune-based antitumour therapies, that strengthen the body's own ability to fightcancer, have attracted great attention in recent years and achieved interesting success rates, especially in malignant melanoma. However, many patients still do not respond to immune-based therapies.

The results from the current study imply that tumour pericytes, a cell that is part of the tumour blood vessels, critically manipulate the tumour environment, helping the cancer cells escape immune surveillance.

"Understanding the interplay between tumour pericytes, malignant cells, and the immune system might help in designing more personalised and effective therapeutic approaches," says Principal Investigator Guillem Genové at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet.

Tumours evade the immune system by a variety of mechanisms, one of them being the recruitment of so called 'myeloid-derived suppressor cells' (MDSC). MDSCs suppress the ability of killer T-cells to destroy cancer cells. It is known that the more MDSCs present, the worse the prognosis or therapy response of the patient. Tumours secrete signal molecules such as interleukin-6 (IL-6) that help in recruiting MDSCs, but the mechanisms behind IL-6 tumour secretion are quite unknown.

The researchers found that the higher the number of pericytes, the more "normal" the tumour environment looked like. On the contrary, diminished pericyte numbers altered the microenvironment and correlated to higher IL-6 expression from the malignant cells and more MDSCs. They also identified a subset of breast cancer patients who had fewer pericytes and increased MDSCs, correlating to a worse prognosis and more aggressive characteristics of the tumour.

"Our work suggests that ways to increase the numbers of pericytes could potentially decrease IL-6 expression. This could improve cytotoxic T-cell activity and result in better antitumour effect," says Dr Genové.

The research was supported by grants from, among others, the Swedish Cancer Foundation, the Strategic Cancer Research Program (StratCan) and BRECT Breast Cancer Theme Centrum at Karolinska Institutet, and the Swedish Research Council-supported STARGET Linneus Center of Excellence.


Story Source:

Materials provided by Karolinska Institutet. Note: Content may be edited for style and length.


Journal Reference:

  1. JongWook Hong, Nicholas P. Tobin, Helene Rundqvist, Tian Li, Marion Lavergne, Yaiza García-Ibáñez, Hanyu Qin, Janna Paulsson, Manuel Zeitelhofer, Milena Z. Adzemovic, Ingrid Nilsson, Pernilla Roswall, Johan Hartman, Randall S. Johnson, Arne Östman, Jonas Bergh, Mirjana Poljakovic, Guillem Genové. Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells. Journal of the National Cancer Institute, 2015; 107 (10): djv209 DOI: 10.1093/jnci/djv209

Cite This Page:

Karolinska Institutet. "Blood vessel cells help tumors evade the immune system." ScienceDaily. ScienceDaily, 24 August 2015. <www.sciencedaily.com/releases/2015/08/150824064921.htm>.
Karolinska Institutet. (2015, August 24). Blood vessel cells help tumors evade the immune system. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/08/150824064921.htm
Karolinska Institutet. "Blood vessel cells help tumors evade the immune system." ScienceDaily. www.sciencedaily.com/releases/2015/08/150824064921.htm (accessed May 23, 2017).

RELATED STORIES